JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol.20, no.3, pp.421-425, 2005 (SCI-Expanded)
Background: Hepatic hydatidosis still remains as a serious problem in general surgery. Recurrence and/or secondary hydatidosis rates are up to 25% in the cases treated with surgery alone. Albendazole is the most commonly used drug in the medical treatment of echinococcosis. The aim of the present study was to evaluate the effect of albendazole using the intraoperative and perioperative periods as dual therapy.